Identification of key interactions between SARS-CoV-2 main protease and inhibitor drug candidates

The number of cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (COVID-19) has reached over 114,000. SARS-CoV-2 caused a pandemic in Wuhan, China, in December 2019 and is rapidly spreading globally. It has been reported that peptide-like anti-HIV-1 drugs are effective a...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshino, Ryunosuke, Yasuo, Nobuaki, Sekijima, Masakazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385649/
https://www.ncbi.nlm.nih.gov/pubmed/32719454
http://dx.doi.org/10.1038/s41598-020-69337-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385649/
https://www.ncbi.nlm.nih.gov/pubmed/32719454
http://dx.doi.org/10.1038/s41598-020-69337-9

Ejemplares similares